The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Vericel Corporation(NASDAQ:VCEL) 
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellula...
Website: http://vcel.com
Founded: 1989
Full Time Employees: 241
Sector: Healthcare
Industry: Biotechnology
Vericel Days Payable Outstanding ttm (DPO)
Vericel Days Receivable Outstanding ttm (DSO)
Vericel Days Inventory Outstanding ttm (DIO)
Vericel Op Cashflow Per Share ttm
Vericel Free Cashflow Per Share ttm
Vericel Cash Per Share ttm
Vericel P/S ratio ttm
Vericel (GAAP) P/E ratio ttm
Vericel P/B ratio ttm
No extra charts and metrics for this ticker.